Suche Medizinische Publikationen
Suche Abbildungen und Grafiken
Medizinprodukte - Labortechnik
Antidotarium (Stand 2012)
Phytokodex (Stand 2012)
Fachbücher
Patientenliteratur
Grunert S, Ebel D, Schlack W, Thämer V Intracoronary and Intravenous Magnesium Does Not Reduce Myocardial Infarct Size in a Canine Model of Regional Ischaemia and Reperfusion Journal of Clinical and Basic Cardiology 2002; 5 (1): 23-28 PDF Summary Overview
| ||||||||||||
Figure/Graphic 4: Magnesium-Kalium-Aspartat - Herzfrequenz Heart rate during administration of intravenous magnesium potassium aspartate in ischaemia-reperfusion. HR = heart rate; Occl. = time period of left anterior descending artery occlusion; Reperfusion = time period of reperfusion of the left anterior descending artery; Infusion i.v., time period when magnesium potassium aspartate or vehicle was infused intravenously; values are means +/- SD; Mg2+-K+ vs Control; P < 0.001 |
Figure/Graphic 4: Magnesium-Kalium-Aspartat - Herzfrequenz
Heart rate during administration of intravenous magnesium potassium aspartate in ischaemia-reperfusion. HR = heart rate; Occl. = time period of left anterior descending artery occlusion; Reperfusion = time period of reperfusion of the left anterior descending artery; Infusion i.v., time period when magnesium potassium aspartate or vehicle was infused intravenously; values are means +/- SD; Mg2+-K+ vs Control; P < 0.001 |